Earlier this year, Israel-based pharmaceutical cannabis company Panaxia Pharmaceutical Industries appointed Nobel Prize winner in chemistry, Prof. Aaron Ciechanover (72) as a senior member on its advisory committee.
Prof. Ciechanover, an Israeli biologist, got the highest honor from the Nobel Foundation for discovering ubiquitin‐mediated protein degradation. He is now one of the very few Nobel Prize winners actually working in the cannabis space.
‘A World Of Mystery’
During an exclusive interview held a few weeks ago, Prof. Ciechanover said that, while he recognizes “cannabis is a world of mystery,” his decision to join Panaxia was not driven by “the mystic aspect” of the plant, but rather by his desire to help with the science behind the company’s products.
“I’ve also learned a great deal about traditional Chinese medicine, and it too can be used as a source of many treasures regarding the plant; and let’s not forget that commercial companies are investing heavily in research and development,” he added.
Panaxia will be seeking to promote collaborations with researchers and therapists around the world, as well as potential licensing agreements. Prof. Ciechanover will be assisting the team in these tasks.
From Chemistry To Cannabis
Prof. Ciechanover has a background in …